Supplements

  • Volume 11, Supplement 2 (Sep/Oct 2020)
  • Volume 11, Supplement 1 (Apr 2020)
  • Volume 10, Supplement 4 (Nov/Dec 2019)
  • Volume 10, Supplement 3 (May/Jun 2019)
  • Volume 10, Supplement 2 (Mar 2019)
  • Volume 10, Supplement 1 (Mar 2019)
  • Volume 9, Supplement 1 (Nov/Dec 2018)
  • Volume 8, Supplement 7 (Dec 2017)
  • Volume 8, Supplement 6 (Dec 2017)
  • Volume 8, Supplement 5 (Oct 2017)
  • Volume 8, Supplement 4 (Oct 2017)
  • Volume 8, Supplement 3 (Oct 2017)
  • Volume 8, Supplement 2 (Sep/Oct 2017)
  • Volume 8, Supplement 1 (Jul/Aug 2017)
  • Volume 7, Supplement 2 (Nov/Dec 2016)
  • Volume 7, Supplement 1 (Mar 2016)
  • Volume 6, Supplement 1 (Mar/Apr 2015)
  • Volume 5, Supplement 1 (May/Jun 2014)
  • Volume 4, Supplement 1 (Nov/Dec 2013)
  • Volume 3, Supplement 1 (Nov/Dec 2012)
  • Volume 2, Supplement 2 (Sep/Oct 2011)
  • Volume 2, Supplement 1 (May/Jun 2011)

    The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    This CME/CE/CPE accredited supplement is jointly provided by:

    HSME NewlogoHSME Newlogo

    JADPRO 5 Fig02

    JADPRO 5 Fig03

    Faculty

    Diane Cope, PhD, ARNP-BC, AOCNP®, Florida Cancer Specialists and Research Institute 

    Kimberly M. Hicks, PharmD, MHA, HHCS Health Group of Companies

    John Novak, CHA, PA-C, Rocky Mountain Cancer Centers and University of Colorado School of Medicine

    Susan Scherer, RN, BSN, OCN®, RN Cancer Guides Solutions 

    This activity is supported by unrestricted educational grants from AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Novartis Pharmaceutical Corporation; and Taiho Oncology, Inc.

    Editorial

    A Letter From The Guest Editor



    Read More
    Review Article

    The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

    Kimberly M. Hicks,(1) PharmD, MHA, Diane Cope,(2) PhD, ARNP-BC, AOCNP®, John Novak,(3) CHA, PA-C, and Susan Scherer,(4) RN, BSN, OCN

    Read More

    The Emerging Role of Molecular Testing in Ovarian Cancer

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    This CME/CEU accredited supplement is jointly provided by:

    hme logo

    JADPRO 5 Fig02

    JADPRO 5 Fig03

    Faculty

    Courtney B. Cortez, NP, Indiana University Simon Cancer Center—IU Health

    Cynthia L. Hunter, MS, LCGC, Indiana University Health

    Patrick J. Kiel, PharmD, BCPS, BCOP, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health

    Jeanne M. Schilder, MD, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health

    This supplement is supported by an educational grant from AstraZeneca.

    Editorial

    The Rise of Genetic Testing in Managing Patients With Ovarian Cancer

    Patrick J. Kiel, PharmD, BCPS, BCOP

    Read More
    Review Article

    The Emerging Role of Molecular Testing in Ovarian Cancer

    Patrick J. Kiel,(1) PharmD, BCPS, BCOP, Courtney B. Cortez,(2) NP, Cynthia L. Hunter,(3) MS, LCGC, and Jeanne M. Schilder,(1) MD

    Read More

    The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    This CME/CEU accredited supplement is jointly provided by:

    hme logo

    JADPRO 5 Fig02

    JADPRO 5 Fig03

    Faculty

    Liang Cheng, MD, Indiana University School of Medicine 

    Gregory Durm, MD, Indiana University Simon Cancer Center—IU Health

    Patrick J. Kiel, PharmD, BCPS, BCOP, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health

    Anna Livers-Ertel, ANP-BC, MSN, OCN®, Franciscan Health Cancer Center

    This supplement is supported by an educational grant from AstraZeneca.

    Editorial

    The Rise of Genetic Testing in Managing Patients With Non–Small Cell Lung Cancer

    Patrick J. Kiel, PharmD, BCPS, BCOP

    Read More
    Review Article

    The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer

    Patrick J. Kiel,(1),(2) PharmD, BCPS, BCOP, Liang Cheng,(1) MD, Anna Livers-Ertel,(3) ANP-BC, MSN, OCN®, and Gregory Durm,(2) MD

    Read More

    Genetic Counseling in Gynecologic Oncology: What Advanced Practitioners Need to Know

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    This CME/CEU accredited supplement is jointly provided by:

    hme logo

    sgo logo

    APSHO LOGO HORZ

    jadpro sgo logo

    Faculty

    Heather Hampel, MS, LGC
    The Ohio State University Comprehensive Cancer Center

    Brianna Hoffner, MSN, ANP-BC, AOCNP®
    University of Colorado Cancer Center

    Leigha Senter-Jamieson, MS, LGC
    The Ohio State University Wexner Medical Center

    Paula Anastasia, RN, MN, AOCN®
    Cedars-Sinai Medical Center

    This supplement is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP

    Save

    Save

    Save

    Save

    Save

    Save

    Save

    Save

    Save

    Save

    Editorial

    Introduction

    Heather Hampel, MS, LGC, Guest Editor

    Read More
    Review Article

    Lynch Syndrome and Immunotherapy

    Heather Hampel, MS, LGC, and Brianna Hoffner, MSN, ANP-BC, AOCNP®

    Read More
    Review Article

    BRCA-Related Ovarian Cancers and the Role of PARP Inhibitor Therapy

    Leigha Senter, MS, LGC, and Paula Anastasia, RN, MN, AOCN®

    Read More

    Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    A continuing education article for physicians, PAs, doctors of nursing practice, nurse practitioners, advanced practice nurses including clinical nurse specialists, and other advanced degree nurses.

    JADPRO Logo

     

    Faculty

    Angela DeMichele, MD, MSCE, Alan and Jill Miller Endowed Chair in Breast Cancer Excellence and Professor of Medicine and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Jennie Greco Lattimer, MSN, BSN, CRNP, Oncology Nurse Practitioner, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA


    This supplement is supported by an educational grant from Genentech.

    Continuing Education

    Continuing Education Information



    Read More
    Continuing Education

    Meet the Team



    Read More
    Continuing Education

    Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model

    Angela DeMichele, MD, MSCE; Jennie Greco Lattimer, MSN, BSN, CRNP; and Rachel F.

    Read More
    Appendix

    Appendix

    Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model

    Read More

    The Advanced Practitioner's Guide to Multiple Myeloma

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    A continuing education activity for nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

    This CME/CE/CEU accredited supplement is jointly provided by

    IMF Logo

     

    Annenberg Logo

     

    JADPRO Logo

    This supplement has been developed by members of the International Myeloma Foundation Nurse Leadership Board

    Nurse Leadership Board Logo

     

    Faculty

    Page Bertolotti, RN, BSN, OCN, Samuel Oschin Cancer Center at Cedars-Sinai Medical Center

    Kevin Brigle, PhD, NP, VCUHS Massey Cancer Center

    Donna D. Catamero, ANP-BC, OCN, CCRC, Mount Sinai Medical Center

    Kathleen Colson, RN, BSN, BS, Dana-Farber Cancer Center

    Hollie Devine, MSN, ANP-BC, The Ohio State University Medical Center James Cancer Hospital

    Deborah Doss, RN, OCN, Dana-Farber Cancer Center

    Beth Faiman, PhD, MSN, APRN-BC, AOCN, Cleveland Clinic Taussig Cancer Institute

    Elizabeth Finley-Oliver, RN, BSN, OCN, H. Lee Moffitt Cancer Center and Research Institute

    Charise Gleason, MSN, NP-BC, AOCNP, Winship Cancer Institute of Emory University

    Sandra Kurtin, RN, MSN, AOCN, ANP-C, The University of Arizona Cancer Center

    Patricia A. Mangan, RN, MSN, APRN-BC, Abramson Cancer Center at the University of Pennsylvania

    Ali McBride, PharmD, MS, BCPS, BCOP, The University of Arizona Cancer Center

    Ann McNeill, RN, MSN, APN, John Theurer Cancer Center at HUMC

    Teresa Miceli, RN, BSN, OCN, Mayo Clinic-Rochester

    Kimberly Noonan, RN, ANP, AOCN, Dana-Farber Cancer Center

    Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center

    Sandra Rome, RN, MN, AOCN, CNS, Cedars-Sinai Medical Center

    Joseph Tariman, PhD, ANP-BC, DePaul University

    Daniel Verina, BS, BSN, MSN, ACNP-BC, Mount Sinai Medical Center

    This supplement is provided by independent educational grants from the following companies: Takeda Oncology, Celgene Corporation, Binding Site, and Adaptive Biotechnologies.

    Continuing Education

    Continuing Education Information



    Read More
    Editorial

    The Future is Bright

    Sandra Kurtin, RN, MSN, AOCN®, ANP-C

    Read More
    Editorial

    The Continuum of Care in Multiple Myeloma Redefined: Challenges and Opportunities

    Sandra Kurtin, RN, MSN, AOCN®, ANP-C, Guest Editor

    Read More
    Review Article

    Sequencing of Treatment and Integration of Clinical Trials

    Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Charise Gleason,(2) MSN, NP-BC, AOCNP®, Kathleen Colson,(3) RN, BSN, BS, Ann McNeill,(4) RN, MSN, APN, and Donna Catamero,(5) ANP-BC, OCN®, CCRC, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Review Article

    Palliative Care in Multiple Myeloma

    Tiffany Richards,(1) MS, ANP, AOCNP®, and Kevin Brigle,(2) PhD, NP, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Prescriber's Corner

    New Agents in the Treatment of Multiple Myeloma

    Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Ali McBride,(2) PharmD, MS, BCPS, BCOP, Hollie Devine,(3) MSN, ANP-BC, Charise Gleason,(4) MSN, NP-BC, AOCNP®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Prescriber's Corner

    Monoclonal Antibodies in the Treatment of Multiple Myeloma

    Charise Gleason,(1) MSN, NP-BC, AOCNP®, Hollie Devine,(2) MSN, ANP-BC, Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, Deborah Doss,(4) RN, OCN®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Grand Rounds

    Updates in the Diagnosis and Monitoring of Multiple Myeloma

    Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Page Bertolotti,(2) RN, BSN, OCN®, Kevin Brigle,(3) PhD, NP, and Daniel Verina,(4) BS, BSN, MSN, ACNP-BC, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Practice Matters

    Adherence, Persistence, and Treatment Fatigue in Multiple Myeloma

    Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Kathleen Colson,(2) RN, BSN, BS, Joseph Tariman,(3) PhD, ANP-BC, Beth Faiman,(4) PhD, MSN, APRN-BC, AOCN®, and Elizabeth Finley-Oliver,(5) RN, BSN, OCN, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More
    Tools and Technology

    Resources for Patients and Caregivers With Multiple Myeloma and Their Providers

    Kevin Brigle, PhD, NP, on behalf of The International Myeloma Foundation Nurse Leadership Board

    Read More
    Appendix

    Multiple Myeloma Treatment Options for Newly Diagnosed, Relapsed, and Refractory Disease

    Kimberly Noonan,(1) RN, ANP, AOCN®, Teresa S. Miceli,(2) RN, BSN, OCN®, Patricia Mangan,(3) RN, MSN, APRN-BC, and Sandra Rome,(4) RN, MN, AOCN®, CNS, on behalf of the International Myeloma Foundation Nurse Leadership Board

    Read More

    Monitoring, Treatment Resistance, and Treatment Failure in Chronic Myeloid Leukemia

    Breaking Barriers to Improved Outcomes

    Jorge Eduardo Cortes, MD
    The University of Texas MD Anderson Cancer Center
    Houston, Texas

    John M. Goldman, DM, FRCP, FRCPath, FMedSci
    Imperial College
    London, United Kingdom

    Timothy P. Hughes, MD, MBBS
    Centre for Cancer Biology
    Adelaide, Australia

    Faculty Perspectives by:

    Patricia S. Ault, RN, FNP, and Mary Beth Rios, CCRP, RN
    The University of Texas MD Anderson Cancer Center
    Houston, Texas

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    CNE provided by MediCom Worldwide, Inc.

    This activity is supported by an unrestricted educational grant from ARIAD Pharmaceuticals, Inc.

     

    Continuing Education

    Continuing Education Information



    Read More
    Review Article

    Monitoring, Treatment Resistance, and Treatment Failure in CML: Breaking Barriers to Improved Outcomes

    Jorge Eduardo Cortes, MD(1). John M. Goldman, DM, FRCP, FRCPath, FMedSci(2), and Timothy P. Hughes, MD, MBBS(3); Faculty Perspectives by Patricia S. Ault, RN, FNP(1), and Mary Beth Rios, CCRP, RN(1)

    Read More

    Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management

    Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

    Carrie F. Daly, MS, RN, AOCN®, Rush University Medical Center

    Annette M. Quinn, MSN, RN, University of Pittsburgh Medical Center

    Oral mucositis remains one of the most painful and debilitating side effects of cancer therapy. A working knowledge of the risk factors for oral mucositis and oral cavity assessment protocols is essential to early identification of signs and symptoms in high-risk patients. The use of evidence-based guidelines and patient education will facilitate symptom management and supportive care strategies designed to avoid reductions, delays, or discontinuation of cancer treatment.

    CE provided by:

    IMER-logo.jpg

    Continuing Education

    Continuing Education Information



    Read More
    Review Article

    Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management

    Carrie F. Daly, MS, RN, AOCN®, and Annette M. Quinn, MSN, RN

    Read More
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.